231 related articles for article (PubMed ID: 9253829)
1. Comparative in vitro activity of doxycycline and oxytetracycline against porcine respiratory pathogens.
Bousquet E; Morvan H; Aitken I; Morgan JH
Vet Rec; 1997 Jul; 141(2):37-40. PubMed ID: 9253829
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Pasteurella multocida and Salmonella choleraesuis isolates from pigs.
Raemdonck DL; Tanner AC; Tolling ST; Michener SL
Vet Rec; 1994 Jan; 134(1):5-7. PubMed ID: 8128570
[TBL] [Abstract][Full Text] [Related]
3. What is the true in vitro potency of oxytetracycline for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida?
Dorey L; Hobson S; Lees P
J Vet Pharmacol Ther; 2017 Oct; 40(5):517-529. PubMed ID: 28101885
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of doxycycline in feed for the control of pneumonia caused by Pasteurella multocida and Mycoplasma hyopneumoniae in fattening pigs.
Bousquet E; Pommier P; Wessel-Robert S; Morvan H; Benoit-Valiergue H; Laval A
Vet Rec; 1998 Sep; 143(10):269-72. PubMed ID: 9787419
[TBL] [Abstract][Full Text] [Related]
5. Treatment of pigs experimentally infected with Mycoplasma hyopneumoniae, Pasteurella multocida, and Actinobacillus pleuropneumoniae with various antibiotics.
Stipkovits L; Miller D; Glavits R; Fodor L; Burch D
Can J Vet Res; 2001 Oct; 65(4):213-22. PubMed ID: 11768127
[TBL] [Abstract][Full Text] [Related]
6. Impact of growth matrix on pharmacodynamics of antimicrobial drugs for pig pneumonia pathogens.
Dorey L; Lees P
BMC Vet Res; 2017 Jun; 13(1):192. PubMed ID: 28645327
[TBL] [Abstract][Full Text] [Related]
7. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella multocida and Actinobacillus pleuropneumoniae associated with porcine respiratory disease.
Shryock TR; Staples JM; DeRosa DC
J Vet Diagn Invest; 2002 Sep; 14(5):389-95. PubMed ID: 12296390
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial resistance genes in Actinobacillus pleuropneumoniae, Haemophilus parasuis and Pasteurella multocida isolated from Australian pigs.
Dayao D; Gibson JS; Blackall PJ; Turni C
Aust Vet J; 2016 Jul; 94(7):227-31. PubMed ID: 27349882
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial activity of tilmicosin against Pasteurella multocida and Actinobacillus pleuropneumoniae isolated from pneumonic lesions in swine.
Inamoto T; Kikuchi K; Iijima H; Kawashima Y; Nakai Y; Ogimoto K
J Vet Med Sci; 1994 Oct; 56(5):917-21. PubMed ID: 7865594
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing the potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
Dorey L; Hobson S; Lees P
Res Vet Sci; 2017 Apr; 111():93-98. PubMed ID: 28113129
[TBL] [Abstract][Full Text] [Related]
11. In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Actinobacillus pleuropneumoniae from pigs.
Blackall PJ; Asakawa T; Graydon RJ; White M; Adamson M; Wade LK; Lowe LB
Aust Vet J; 1995 Jan; 72(1):35-6. PubMed ID: 8787526
[No Abstract] [Full Text] [Related]
12. In vitro activity of five tetracyclines and some other antimicrobial agents against four porcine respiratory tract pathogens.
Pijpers A; Van Klingeren B; Schoevers EJ; Verheijden JH; Van Miert AS
J Vet Pharmacol Ther; 1989 Sep; 12(3):267-76. PubMed ID: 2810475
[TBL] [Abstract][Full Text] [Related]
13. PK and PK/PD of doxycycline in drinking water after therapeutic use in pigs.
Prats C; El Korchi G; Giralt M; Cristòfol C; Peña J; Zorrilla I; Saborit J; Pérez B
J Vet Pharmacol Ther; 2005 Dec; 28(6):525-30. PubMed ID: 16343284
[TBL] [Abstract][Full Text] [Related]
14. Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.
Blondeau JM; Fitch SD
PLoS One; 2019; 14(1):e0210154. PubMed ID: 30629633
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic/pharmacodynamic integration and modelling of oxytetracycline for the porcine pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
Dorey L; Pelligand L; Cheng Z; Lees P
J Vet Pharmacol Ther; 2017 Oct; 40(5):505-516. PubMed ID: 28090673
[TBL] [Abstract][Full Text] [Related]
16. Potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida: Comparison of growth media.
Dorey L; Hobson S; Lees P
Res Vet Sci; 2017 Apr; 111():43-48. PubMed ID: 27940285
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility monitoring of respiratory tract pathogens isolated from diseased cattle and pigs across Europe: the VetPath study.
de Jong A; Thomas V; Simjee S; Moyaert H; El Garch F; Maher K; Morrissey I; Butty P; Klein U; Marion H; Rigaut D; Vallé M
Vet Microbiol; 2014 Aug; 172(1-2):202-15. PubMed ID: 24837878
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of serovar-independent ELISA antigens of Actinobacillus pleuropneumoniae in pigs, following experimental challenge with A. pleuropneumoniae, Mycoplasma hyopneumoniae and Pasteurella multocida.
Eamens GJ; Gonsalves JR; Whittington AM; Turner B
Aust Vet J; 2012 Jun; 90(6):225-34. PubMed ID: 22632286
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility of Pasteurella multocida isolated from cattle and pigs.
Yoshimura H; Ishimaru M; Endoh YS; Kojima A
J Vet Med B Infect Dis Vet Public Health; 2001 Sep; 48(7):555-60. PubMed ID: 11666039
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of various quinolone antibacterial agents against veterinary mycoplasmas and porcine respiratory bacterial pathogens.
Hannan PC; O'Hanlon PJ; Rogers NH
Res Vet Sci; 1989 Mar; 46(2):202-11. PubMed ID: 2704885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
